Artelo Biosciences Information Ratio
The Information Ratio measures excess return (alpha) per unit of tracking error relative to a benchmark. Unlike the Sharpe Ratio, which uses total volatility, the Information Ratio isolates only the variability of the alpha component — the return attributable to active decisions rather than passive market exposure. Below is Artelo Biosciences's current Information Ratio with peer comparisons and related risk metrics.
Current Information Ratio Value
At 0, Artelo Biosciences exhibits slight underperformance relative to the benchmark on a risk-adjusted basis in Information Ratio. The negative value indicates Artelo Biosciences has not kept pace with its benchmark after accounting for tracking error.
| = | 0 |
| ER[a] | = | Expected return on investing in Artelo Biosciences |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Artelo Biosciences |
Information Ratio Peers Comparison
Information Ratio Relative To Other Indicators
The chart below plots Information Ratio against Maximum Drawdown for Artelo Biosciences and its peers. Each point represents one equity — position along the horizontal axis shows Information Ratio while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Information Ratio |
Maximum Drawdown |
Methodology, Assumptions & Data Sources
Artelo Biosciences has a current Information Ratio reading of 0. Artelo Biosciences' Information Ratio is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. Indicator accuracy depends on data continuity across the calculation period. Gaps in trading history may affect the output.